Psychological Resilience and Mental Wellbeing Mitigate the Risk of Irritable Bowel Syndrome
Zhang M. et al, (2025), American Journal of Gastroenterology
Peripheral blood DNA methylation signatures to predict treatment response in Crohn's disease - Authors' reply.
Li Yim AYF. et al, (2025), The lancet. Gastroenterology & hepatology, 10, 973 - 974
Development and validation of peripheral blood DNA methylation signatures to predict response to biological therapy in adults with Crohn's disease (EPIC-CD): an epigenome-wide association study.
Joustra VW. et al, (2025), The lancet. Gastroenterology & hepatology, 10, 818 - 830
Age-related impairment of intestinal inflammation resolution through an eicosanoid-immune-microbiota axis.
Goepp M. et al, (2025), Cell host & microbe, 33, 671 - 687.e6
Composition of plant-based diets and the incidence and prognosis of inflammatory bowel disease: a multinational retrospective cohort study.
Chen J. et al, (2025), The Lancet regional health. Europe, 52
Association of the HLA-DQA1*05 Allelic Gene Variants with Immunogenicity to Anti-TNF therapeutics-Important Differences Between Infliximab and Adalimumab.
Ternette N. et al, (2025), Journal of Crohn's & colitis, 19
Prenatal cannabis exposure is associated with alterations in offspring DNA methylation at genes involved in neurodevelopment, across the life course.
Noble AJ. et al, (2025), Molecular psychiatry, 30, 1418 - 1429
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals
Mellors J. et al, (2025), Nature Communications, 16
The Circulating Methylome in Childhood-Onset Inflammatory Bowel Disease.
Noble A. et al, (2025), Journal of Crohn's & colitis, 19
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota research.
Wyatt NJ. et al, (2025), EBioMedicine, 112
Analysis of the circulating methylome in 155 IBD-discordant twin pairs from UK and Scandinavia highlights differential variance and association with active inflammation
Nowak J. et al, (2025), JOURNAL OF CROHNS & COLITIS, 19, i319 - i320
Endoscopic severity and C-reactive protein predict initial and 12-month outcomes of second-line medical therapy in acute severe ulcerative colitis: the RESCUE-ASC study
Kakkadasam Ramaswamy P. et al, (2025), FRONTLINE GASTROENTEROLOGY
Epigenetic age acceleration and methylation differences in IgG4-related cholangitis and primary sclerosing cholangitis.
Noble A. et al, (2025), Clinical epigenetics, 17
Exposure to air pollution increases susceptibility to ulcerative colitis through epigenetic alterations in CXCR2 and MHC class III region.
Chen J. et al, (2024), EBioMedicine, 110
Arthritis complicating inflammatory bowel disease- the future is now.
Song K. et al, (2024), The Lancet. Rheumatology, 6, e805 - e810
External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab.
Pierre N. et al, (2024), Gut, 73, 1965 - 1973
Intestinal Inflammation and Extraintestinal Disease: Understanding Dynamic Risk.
Ashton JJ. et al, (2024), Gastroenterology, 167, 205 - 208
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.
Satsangi J. et al, (2024), The lancet. Gastroenterology & hepatology, 9, 591 - 592
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource
Kapizioni C. et al, (2024), Journal of Crohn's and Colitis, 18, 790 - 800
Dietary Inflammatory Indices Are Not Associated With Inflammatory Bowel Disease Incidence and Progression.
Wellens J. et al, (2024), Inflammatory bowel diseases, 30, 1036 - 1041